News

Phase 1 Clinical Trial Offers FDA Fast-Tracked Drug for Relapsed/Refractory AML and MDS

A phase 1 clinical trial underway at Roswell Park Comprehensive Cancer Center offers a promising treatment option for patients with relapsed or refractory acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS).

Video

Clinical CAR T-cell Trial for Multiple Myeloma Suggests Possible “Cure”

For the first time, patients on a new CAR T-cell therapy for multiple myeloma are experiencing remission long enough to be cautious deemed cured of their disease.

News

Roswell Park’s Stem Cell Transplant Program Recognized by Optum as Center of Excellence

Health services leader Optum has recognized Roswell Park Comprehensive Cancer Center as a Center of Excellence (COE) for the stem cell transplant program provided through its Transplant & Cellular Therapy Center.

Video

Exploring HIPEC Treatment as an Option for Peritoneal Cancers

HIPEC is part of a two-step process for cancers that either originate in the peritoneal cavity or migrate there from an organ.

News

Research Leaders Across New York State Form Empire State Cellular Therapy Consortium

To expand on early progress in the emerging field of cell and gene therapy, five research centers across New York State are collaborating to develop new cell therapies for cancer and other diseases.

Video

Roswell Park Adopts New Robotic Bronchoscopy System for More Accurate Biopsies

Roswell Park is utilizing a new tool, the Galaxy robotic bronchoscope system, for more accurate lung nodule imaging and biopsies.